Multimodal PET-MR segmentation for glioblastoma: complementarity for treatment planning and recurrence definition [0.03%]
用于胶质母细胞瘤治疗计划和复发定义的多模态PET-MR分割方法
Alejandro Mora-Rubio,Dejan Kuhn,Carolina Bravo-Vergara et al.
Alejandro Mora-Rubio et al.
Background: In patients with Glioblastoma (GBM), Magnetic Resonance (MR) is used for tumour diagnosis and treatment planning. Positron Emission Tomography (PET) with O-(2)-18 F-Fluoroethyl-L-Tyrosine (FET) has been recomm...
Habitat-based imaging and peritumoral radiomics on ultrasound images for predicting lymphovascular invasion in breast invasive ductal carcinoma: a two-center study [0.03%]
基于乳腺浸润性导管癌淋巴血管侵袭的超声影像特征及肿瘤周周邻组织的影像组学预测模型：两项中心研究
Taixia Liu,Guojia Zhao,Wei Wei et al.
Taixia Liu et al.
Purpose: This study aimed to evaluate the feasibility of employing habitat-based radiomic distributions in ultrasound (US) images to quantitatively characterize intratumoral heterogeneity. It also explored the potential o...
Magnetic resonance biomarkers in detection and characterisation of ovarian cancer: is magnetic resonance spectroscopy ready for clinical use? [0.03%]
卵巢癌检测与表征的磁共振生物标志物：磁共振波谱是否已准备好用于临床？
Marianthi Vasiliki Papoutsaki,Marc Eric Miquel,Joe Martin et al.
Marianthi Vasiliki Papoutsaki et al.
Ovarian cancer is a major cause of cancer-related mortality in women, largely due to late-stage diagnosis and challenges in preoperative characterisation of adnexal masses. Multiparametric MRI, incorporating diffusion-weighted (DW) and dyna...
Patient understanding of AI-simplified oncology imaging reports requires further validation [0.03%]
患者对AI简化肿瘤影像报告的理解仍需进一步验证
Wei Wei,Changyu Du,Jiageng Shen
Wei Wei
Ribeiro and colleagues offer timely evidence that large language models can make oncology imaging reports more accessible to radiologists and patient and public involvement representatives. Their findings also highlight an important distinc...
Development and multicohort external validation of a preoperative [18F]PSMA-1007 PET-derived deep learning score and multimodal model for predicting biochemical recurrence-free survival after radical prostatectomy [0.03%]
开发并利用多队列外部验证的基于[18F]PSMA-1007-PET的深度学习评分和多模态模型预测根治术后无生化复发生存率
Tiancheng Li,Nina Xu,Xiaofang Yan et al.
Tiancheng Li et al.
Purpose: To develop and validate a preoperative [18F]PSMA-1007 PET-derived deep learning score (DLS) and an integrated model combining DLS, D'Amico risk classification, and SUVmax for predicting biochemical recurrence-fre...
Elastography for distinguishing lymphoma from benign and metastatic lymphadenopathy: a systematic review and Bayesian meta-analysis [0.03%]
弹性图鉴别淋巴瘤与良性及转移性淋巴结病变的系统评价和贝叶斯Meta分析
Fatemeh Mahdavi Sabet,Shayan Forghani,Amirhossein Shahsavand et al.
Fatemeh Mahdavi Sabet et al.
Background: Differentiating lymphoma from benign and metastatic lymphadenopathies using conventional ultrasound remains clinically challenging. Despite the utility of ultrasound elastography in assessing tissue stiffness,...
When PSMA is not enough: the diagnostic blind spots of PSMA PET/CT and the added value of [¹⁸F]FDG in high-risk prostate cancer: dual-tracer cohort study [0.03%]
当PSMA不够用时：PSMA PET/CT的诊断盲点以及在高危前列腺癌中[¹⁸F]FDG的附加价值：双示踪剂队列研究
Efrah Ahmed Ibrahim,Eray Alper
Efrah Ahmed Ibrahim
Purpose: PSMA PET/CT has transformed prostate cancer management, yet its diagnostic utility is not absolute. It fails to detect PSMA-suppressed disease variants, including treatment-induced neuroendocrine prostate cancer ...
Evaluation of audiovisual and auditory interventions on exam anxiety during whole-body magnetic resonance imaging in cancer patients: a quasi-experimental study [0.03%]
评估视听和音频干预措施在癌症患者全身磁共振成像考试焦虑中的效果：准实验研究
Lorenzo Conti,Paul Summers,Marta Mainetti et al.
Lorenzo Conti et al.
Background: WB-MRI is a radiation-free imaging technique widely used in oncology. Despite clinical advantages, WB-MRI can cause significant patient anxiety and claustrophobia, affecting scan completion and patient adheren...
Predictive imaging biomarkers on whole-body diffusion-weighted MRI (WB-DWMRI) and [68Ga]GaPSMA-PET/CT for [177Lu]LuPSMA therapy in metastatic prostate cancer (mCRPC) [0.03%]
全身扩散加权MRI(WB-DWMRI)和[68Ga]GaPSMA- PET / CT预测生物标志物在转移性前列腺癌([177Lu]LuPSMA治疗中的作用）
Minal Padden-Modi,Jan Taprogge,Peter Dutey-Magni et al.
Minal Padden-Modi et al.
Background: This study evaluates the utility of quantitative imaging biomarkers derived from whole-body diffusion-weighted MRI (WB-DWMRI) and [68Ga]GaPSMA-PET/CT in predicting lesion-level response to [177Lu]LuPSMA therap...
Correction to: [¹⁸F]PSMA-1007 and [¹⁸F]FDG PET/CT in patients with metastatic triple-negative breast cancer: a prospective head-to-head comparison and assessment of PSMA-targeted radioligand therapy applicability [0.03%]
对[¹⁹F]PSMA-1007和[¹⁸F]FDG PET/CT在转移性三阴性乳腺癌患者中的比较研究及PSMA靶向放射配体治疗适用性的评估校正叙述
Tatiana Nikolaevna Lazutina,Aleksandr Igorevich Khalimon,Soslan Rolanovich Urtaev et al.
Tatiana Nikolaevna Lazutina et al.